Second, the presence of MSLN(+)CTCs or CTCs detection in a few patients with benign lesions may be related to the specificity limitation of the detection method, or it may be that tumor cells do exist in the patient’s body, and such patients should be followed up closely for confirmation. The gene discussed is MSLN; the disease is neoplasm.